Investor Presentaiton

Production sites overview (1/2) Specialized facilities from experimental to large scale production Malmö Braine Strasbourg Torrance San Diego Ambernath PolyPept de Heritage of PolyPeptide. Large facility for all peptide batch sizes and all segments. ~12,800 m² Site with largest liquid phase synthesis in operations, major solid phase capacity expansion ongoing; facility for all peptide batch sizes and all segments. ~30,000 m² Special focus on innovation and cosmetics. Smaller facility for most peptide segments. ~6,100 m² Mid-sized site, also servicing personalized medicine, handling most peptide batch sizes for all segments; in process to set-up lab space and pilot GMP facility to serve oligonucleotides. ~14,000 m² Designed to efficiently handle smaller peptide batch sizes for all segments, incl. radio-labelled peptides. ~4,800 m² Designed to handle generic peptides, manufactured mostly in mid-sized batches. ~8,100 m² 65 FTE's 67 FTE's 160 FTE's >20 years >10 years 119 FTE's 344 FTE's 271 FTE's >20 years >20 years >30 years >30 years GLOBAL SUPPORT FOR A QUALITY SOLUTION 9 PolyPeptide GROUP

View entire presentation